HUE032157T2 - Triazin vegyületek mint P13 kináz és mTOR inhibitorok - Google Patents

Info

Publication number

HUE032157T2

HUE032157T2 HUE09751541A HUE09751541A HUE032157T2 HU E032157 T2 HUE032157 T2 HU E032157T2 HU E09751541 A HUE09751541 A HU E09751541A HU E09751541 A HUE09751541 A HU E09751541A HU E032157 T2 HUE032157 T2 HU E032157T2

Authority

HU

Hungary

Prior art keywords

rti

esi

ids ids

mmol

cancer

Prior art date

2008-05-23

Links

• Espacenet
• Global Dossier
• Discuss

• 108091000080 Phosphotransferase Proteins 0.000 title description 9
• 102000020233 phosphotransferase Human genes 0.000 title description 9
• 229940043355 kinase inhibitor Drugs 0.000 title 1
• 229940124302 mTOR inhibitor Drugs 0.000 title 1
• 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 title 1
• 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
• 150000003918 triazines Chemical class 0.000 title 1
• 239000000203 mixture Substances 0.000 claims description 69
• 150000001875 compounds Chemical class 0.000 claims description 59
• 206010028980 Neoplasm Diseases 0.000 claims description 26
• 201000011510 cancer Diseases 0.000 claims description 22
• 150000003839 salts Chemical class 0.000 claims description 20
• 239000000126 substance Substances 0.000 claims description 20
• 238000011282 treatment Methods 0.000 claims description 14
• TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 9
• 239000004480 active ingredient Substances 0.000 claims description 8
• 239000003814 drug Substances 0.000 claims description 8
• 206010006187 Breast cancer Diseases 0.000 claims description 7
• 208000026310 Breast neoplasm Diseases 0.000 claims description 7
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 7
• 201000005202 lung cancer Diseases 0.000 claims description 7
• 208000020816 lung neoplasm Diseases 0.000 claims description 7
• 210000002307 prostate Anatomy 0.000 claims description 7
• 229940079593 drug Drugs 0.000 claims description 6
• 230000005856 abnormality Effects 0.000 claims description 5
• 206010003246 arthritis Diseases 0.000 claims description 5
• 206010060862 Prostate cancer Diseases 0.000 claims description 4
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 4
• 208000000453 Skin Neoplasms Diseases 0.000 claims description 4
• 229910052793 cadmium Inorganic materials 0.000 claims description 4
• 208000017169 kidney disease Diseases 0.000 claims description 4
• 201000000849 skin cancer Diseases 0.000 claims description 4
• 206010005003 Bladder cancer Diseases 0.000 claims description 3
• 201000004681 Psoriasis Diseases 0.000 claims description 3
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 3
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 3
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 3
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 2
• 241001377084 Actites Species 0.000 claims 1
• 101150061258 ITSN1 gene Proteins 0.000 claims 1
• LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 claims 1
• 241000862632 Soja Species 0.000 claims 1
• 240000002871 Tectona grandis Species 0.000 claims 1
• DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
• JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 claims 1
• 210000004907 gland Anatomy 0.000 claims 1
• 239000013003 healing agent Substances 0.000 claims 1
• GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 claims 1
• 230000000366 juvenile effect Effects 0.000 claims 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
• 229960004889 salicylic acid Drugs 0.000 claims 1
• 238000009938 salting Methods 0.000 claims 1
• 238000004544 sputter deposition Methods 0.000 claims 1
• 229960005486 vaccine Drugs 0.000 claims 1
• 238000002360 preparation method Methods 0.000 description 98
• 238000000034 method Methods 0.000 description 63
• 238000006243 chemical reaction Methods 0.000 description 62
• 239000007787 solid Substances 0.000 description 60
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 57
• 239000000243 solution Substances 0.000 description 52
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 50
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 48
• 238000004519 manufacturing process Methods 0.000 description 42
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 37
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 37
• 239000002904 solvent Substances 0.000 description 35
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 31
• -1 as naticancer drags Substances 0.000 description 29
• 230000015572 biosynthetic process Effects 0.000 description 29
• 239000000047 product Substances 0.000 description 27
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
• 239000002253 acid Substances 0.000 description 25
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
• 230000000694 effects Effects 0.000 description 20
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 20
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
• 238000004128 high performance liquid chromatography Methods 0.000 description 18
• 125000000217 alkyl group Chemical group 0.000 description 17
• 239000011541 reaction mixture Substances 0.000 description 17
• 239000004202 carbamide Substances 0.000 description 16
• 235000013877 carbamide Nutrition 0.000 description 16
• KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
• 230000008569 process Effects 0.000 description 16
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
• 125000003118 aryl group Chemical group 0.000 description 14
• 235000019439 ethyl acetate Nutrition 0.000 description 14
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
• 239000012043 crude product Substances 0.000 description 13
• 238000000746 purification Methods 0.000 description 13
• 239000000741 silica gel Substances 0.000 description 13
• 229910002027 silica gel Inorganic materials 0.000 description 13
• 229960001866 silicon dioxide Drugs 0.000 description 13
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 12
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
• 239000003112 inhibitor Substances 0.000 description 12
• 239000011651 chromium Substances 0.000 description 11
• 238000012549 training Methods 0.000 description 11
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 10
• 102000004190 Enzymes Human genes 0.000 description 10
• 108090000790 Enzymes Proteins 0.000 description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
• 230000002829 reductive effect Effects 0.000 description 10
• 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 9
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 9
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 9
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 229910052757 nitrogen Inorganic materials 0.000 description 9
• 239000012044 organic layer Substances 0.000 description 9
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 8
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
• 241000124008 Mammalia Species 0.000 description 8
• 239000000499 gel Substances 0.000 description 8
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
• 208000037309 Hypomyelination of early myelinating structures Diseases 0.000 description 7
• 229910052799 carbon Inorganic materials 0.000 description 7
• 210000004027 cell Anatomy 0.000 description 7
• 230000005764 inhibitory process Effects 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 229910052763 palladium Inorganic materials 0.000 description 7
• 239000004575 stone Substances 0.000 description 7
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 6
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
• 230000002401 inhibitory effect Effects 0.000 description 6
• 239000010410 layer Substances 0.000 description 6
• 238000002844 melting Methods 0.000 description 6
• PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
• 239000003921 oil Substances 0.000 description 6
• 229910052760 oxygen Inorganic materials 0.000 description 6
• 238000010992 reflux Methods 0.000 description 6
• 239000002002 slurry Substances 0.000 description 6
• 239000011734 sodium Substances 0.000 description 6
• 229910052717 sulfur Inorganic materials 0.000 description 6
• 241000283690 Bos taurus Species 0.000 description 5
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
• 210000004556 brain Anatomy 0.000 description 5
• 239000012267 brine Substances 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 238000001704 evaporation Methods 0.000 description 5
• 230000008020 evaporation Effects 0.000 description 5
• 235000013305 food Nutrition 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 230000008018 melting Effects 0.000 description 5
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 5
• BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 5
• 239000008188 pellet Substances 0.000 description 5
• 239000000843 powder Substances 0.000 description 5
• 238000003756 stirring Methods 0.000 description 5
• 210000002784 stomach Anatomy 0.000 description 5
• 239000000725 suspension Substances 0.000 description 5
• 235000013616 tea Nutrition 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• 239000003643 water by type Substances 0.000 description 5
• KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 4
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
• 239000005977 Ethylene Substances 0.000 description 4
• 206010061218 Inflammation Diseases 0.000 description 4
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
• 239000004743 Polypropylene Substances 0.000 description 4
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
• 108091008611 Protein Kinase B Proteins 0.000 description 4
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
• 244000269722 Thea sinensis Species 0.000 description 4
• 230000009471 action Effects 0.000 description 4
• 230000004913 activation Effects 0.000 description 4
• 125000004429 atom Chemical group 0.000 description 4
• 239000002585 base Substances 0.000 description 4
• 150000001721 carbon Chemical group 0.000 description 4
• 150000007942 carboxylates Chemical class 0.000 description 4
• 230000003197 catalytic effect Effects 0.000 description 4
• 230000010261 cell growth Effects 0.000 description 4
• 238000004140 cleaning Methods 0.000 description 4
• 239000013078 crystal Substances 0.000 description 4
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
• 238000001914 filtration Methods 0.000 description 4
• 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
• 229910052736 halogen Inorganic materials 0.000 description 4
• 150000002367 halogens Chemical class 0.000 description 4
• 235000012907 honey Nutrition 0.000 description 4
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 230000004054 inflammatory process Effects 0.000 description 4
• 229910052740 iodine Inorganic materials 0.000 description 4
• 239000011630 iodine Substances 0.000 description 4
• 150000002500 ions Chemical class 0.000 description 4
• 229910052744 lithium Inorganic materials 0.000 description 4
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
• 235000019341 magnesium sulphate Nutrition 0.000 description 4
• 235000012054 meals Nutrition 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 239000012071 phase Substances 0.000 description 4
• 229910052698 phosphorus Inorganic materials 0.000 description 4
• 239000011591 potassium Substances 0.000 description 4
• 229910052700 potassium Inorganic materials 0.000 description 4
• 108090000623 proteins and genes Proteins 0.000 description 4
• 235000017550 sodium carbonate Nutrition 0.000 description 4
• 229910000029 sodium carbonate Inorganic materials 0.000 description 4
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
• 239000005909 Kieselgur Substances 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• 101150108015 STR6 gene Proteins 0.000 description 3
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 208000002495 Uterine Neoplasms Diseases 0.000 description 3
• 230000002159 abnormal effect Effects 0.000 description 3
• 239000013543 active substance Substances 0.000 description 3
• 150000001412 amines Chemical class 0.000 description 3
• 230000033115 angiogenesis Effects 0.000 description 3
• 239000004305 biphenyl Substances 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 206010012601 diabetes mellitus Diseases 0.000 description 3
• 229960004679 doxorubicin Drugs 0.000 description 3
• 238000003818 flash chromatography Methods 0.000 description 3
• 239000012530 fluid Substances 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 125000005843 halogen group Chemical group 0.000 description 3
• 229910052739 hydrogen Inorganic materials 0.000 description 3
• 239000005457 ice water Substances 0.000 description 3
• 238000003384 imaging method Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 239000000543 intermediate Substances 0.000 description 3
• 208000032839 leukemia Diseases 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 239000011259 mixed solution Substances 0.000 description 3
• 238000002156 mixing Methods 0.000 description 3
• 229910052759 nickel Inorganic materials 0.000 description 3
• 239000003960 organic solvent Substances 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
• NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 3
• 239000011028 pyrite Substances 0.000 description 3
• 229910052683 pyrite Inorganic materials 0.000 description 3
• 229920006395 saturated elastomer Polymers 0.000 description 3
• 238000010898 silica gel chromatography Methods 0.000 description 3
• 239000011343 solid material Substances 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 235000019640 taste Nutrition 0.000 description 3
• 238000004809 thin layer chromatography Methods 0.000 description 3
• 150000003573 thiols Chemical class 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 3
• 206010046766 uterine cancer Diseases 0.000 description 3
• 210000004291 uterus Anatomy 0.000 description 3
• AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
• UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 description 2
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
• 229910021556 Chromium(III) chloride Inorganic materials 0.000 description 2
• 241000255925 Diptera Species 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 240000007049 Juglans regia Species 0.000 description 2
• 235000009496 Juglans regia Nutrition 0.000 description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 description 2
• 241000234435 Lilium Species 0.000 description 2
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 2
• UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
• 240000008881 Oenanthe javanica Species 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 102000038030 PI3Ks Human genes 0.000 description 2
• 108091007960 PI3Ks Proteins 0.000 description 2
• 102100026456 POU domain, class 3, transcription factor 3 Human genes 0.000 description 2
• 101710133393 POU domain, class 3, transcription factor 3 Proteins 0.000 description 2
• OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
• 206010038389 Renal cancer Diseases 0.000 description 2
• 208000025747 Rheumatic disease Diseases 0.000 description 2
• 229910000831 Steel Inorganic materials 0.000 description 2
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
• 240000008042 Zea mays Species 0.000 description 2
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 150000001299 aldehydes Chemical class 0.000 description 2
• 125000003545 alkoxy group Chemical group 0.000 description 2
• 150000008064 anhydrides Chemical class 0.000 description 2
• RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
• 239000008346 aqueous phase Substances 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 229910052785 arsenic Inorganic materials 0.000 description 2
• RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 229940120638 avastin Drugs 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 206010006007 bone sarcoma Diseases 0.000 description 2
• UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
• YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 230000000739 chaotic effect Effects 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• 125000001309 chloro group Chemical group Cl* 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 2
• 239000011636 chromium(III) chloride Substances 0.000 description 2
• 235000007831 chromium(III) chloride Nutrition 0.000 description 2
• 235000005822 corn Nutrition 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 238000002425 crystallisation Methods 0.000 description 2
• 230000008025 crystallization Effects 0.000 description 2
• 125000004093 cyano group Chemical group *C#N 0.000 description 2
• 208000031513 cyst Diseases 0.000 description 2
• 238000000354 decomposition reaction Methods 0.000 description 2
• 238000004821 distillation Methods 0.000 description 2
• 235000013601 eggs Nutrition 0.000 description 2
• 239000003480 eluent Substances 0.000 description 2
• 239000002158 endotoxin Substances 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 210000002837 heart atrium Anatomy 0.000 description 2
• 125000000623 heterocyclic group Chemical group 0.000 description 2
• 238000004896 high resolution mass spectrometry Methods 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 201000010982 kidney cancer Diseases 0.000 description 2
• 239000004571 lime Substances 0.000 description 2
• 229920006008 lipopolysaccharide Polymers 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• AFCCDDWKHLHPDF-UHFFFAOYSA-M metam-sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 description 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
• 229960005181 morphine Drugs 0.000 description 2
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• GJQIMXVRFNLMTB-UHFFFAOYSA-N nonyl acetate Chemical compound CCCCCCCCCOC(C)=O GJQIMXVRFNLMTB-UHFFFAOYSA-N 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
• 229920001296 polysiloxane Polymers 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• 125000004076 pyridyl group Chemical group 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000000552 rheumatic effect Effects 0.000 description 2
• 230000033764 rhythmic process Effects 0.000 description 2
• 230000001020 rhythmical effect Effects 0.000 description 2
• 238000002390 rotary evaporation Methods 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 239000010802 sludge Substances 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000010959 steel Substances 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 210000004243 sweat Anatomy 0.000 description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
• 210000003462 vein Anatomy 0.000 description 2
• 235000020234 walnut Nutrition 0.000 description 2
• 238000004018 waxing Methods 0.000 description 2
• HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
• ZOKCNEIWFQCSCM-UHFFFAOYSA-N (2-methyl-4-phenylpent-4-en-2-yl)benzene Chemical compound C=1C=CC=CC=1C(C)(C)CC(=C)C1=CC=CC=C1 ZOKCNEIWFQCSCM-UHFFFAOYSA-N 0.000 description 1
• BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 description 1
• BQMDWLHBHLILMV-HVTWWXFQSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O BQMDWLHBHLILMV-HVTWWXFQSA-N 0.000 description 1
• SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
• ORKBYCQJWQBPFG-WOMZHKBXSA-N (8r,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;(8r,9s,13s,14s,17r)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 ORKBYCQJWQBPFG-WOMZHKBXSA-N 0.000 description 1
• ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
• PBBASIKXDKYSLT-UHFFFAOYSA-N 1-piperidin-1-yl-2H-pyrimidine Chemical compound N1(CCCCC1)N1CN=CC=C1 PBBASIKXDKYSLT-UHFFFAOYSA-N 0.000 description 1
• KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 1
• XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 1
• PHELOKYCCWVWFE-UHFFFAOYSA-N 2,2-dimethoxyacetic acid Chemical compound COC(OC)C(O)=O PHELOKYCCWVWFE-UHFFFAOYSA-N 0.000 description 1
• FBKYPSXTNBQAJW-UHFFFAOYSA-L 2,3,4-trihydroxy-4-oxobutanoate;trimethyl-[6-(trimethylazaniumyl)hexyl]azanium Chemical compound OC(=O)C(O)C(O)C([O-])=O.OC(=O)C(O)C(O)C([O-])=O.C[N+](C)(C)CCCCCC[N+](C)(C)C FBKYPSXTNBQAJW-UHFFFAOYSA-L 0.000 description 1
• JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
• 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
• VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
• JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
• NOMDHIWJYVRCNL-UHFFFAOYSA-N 2-fluoro-3-methylbut-2-ene Chemical group CC(C)=C(C)F NOMDHIWJYVRCNL-UHFFFAOYSA-N 0.000 description 1
• BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical group CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 1
• JUJWROOIHBZHMG-VMNATFBRSA-N 3-deuteriopyridine Chemical compound [2H]c1cccnc1 JUJWROOIHBZHMG-VMNATFBRSA-N 0.000 description 1
• 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
• 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• HKJUOMPYMPXLFS-UHFFFAOYSA-N 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid Chemical compound IC1=CC(C(=O)O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 HKJUOMPYMPXLFS-UHFFFAOYSA-N 0.000 description 1
• 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
• JNYLMODTPLSLIF-UHFFFAOYSA-N 6-(trifluoromethyl)pyridine-3-carboxylic acid Chemical group OC(=O)C1=CC=C(C(F)(F)F)N=C1 JNYLMODTPLSLIF-UHFFFAOYSA-N 0.000 description 1
• 101150090751 ATP6V1F gene Proteins 0.000 description 1
• 206010000060 Abdominal distension Diseases 0.000 description 1
• RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
• 101500011049 Abrus precatorius Agglutinin-1 chain A Proteins 0.000 description 1
• 241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 description 1
• 206010063409 Acarodermatitis Diseases 0.000 description 1
• NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical group C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 241001083911 Aeonium Species 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical group [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
• 229910000497 Amalgam Inorganic materials 0.000 description 1
• 235000010585 Ammi visnaga Nutrition 0.000 description 1
• 244000153158 Ammi visnaga Species 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 208000000044 Amnesia Diseases 0.000 description 1
• 208000031091 Amnestic disease Diseases 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 241000239290 Araneae Species 0.000 description 1
• 241001123248 Arma Species 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 101100056833 Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) asaA gene Proteins 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 235000000832 Ayote Nutrition 0.000 description 1
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
• 101150031017 BIP2 gene Proteins 0.000 description 1
• 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 description 1
• 101710177963 Baculoviral IAP repeat-containing protein 7 Proteins 0.000 description 1
• 206010004194 Bed bug infestation Diseases 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• 208000020084 Bone disease Diseases 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• HEDRZPFGACZZDS-UHFFFAOYSA-N CHCl3 Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
• 101150039077 CRCP gene Proteins 0.000 description 1
• 101100234822 Caenorhabditis elegans ltd-1 gene Proteins 0.000 description 1
• 240000009258 Camassia scilloides Species 0.000 description 1
• 241000985905 Candidatus Phytoplasma solani Species 0.000 description 1
• 235000002566 Capsicum Nutrition 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 208000031229 Cardiomyopathies Diseases 0.000 description 1
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
• 208000002177 Cataract Diseases 0.000 description 1
• 241000397426 Centroberyx lineatus Species 0.000 description 1
• 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
• 240000003538 Chamaemelum nobile Species 0.000 description 1
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
• 241001414835 Cimicidae Species 0.000 description 1
• 241000132536 Cirsium Species 0.000 description 1
• 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
• RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 241000272201 Columbiformes Species 0.000 description 1
• 206010010071 Coma Diseases 0.000 description 1
• 235000001543 Corylus americana Nutrition 0.000 description 1
• 235000007466 Corylus avellana Nutrition 0.000 description 1
• 240000007582 Corylus avellana Species 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• 229910016553 CuOx Inorganic materials 0.000 description 1
• 240000004244 Cucurbita moschata Species 0.000 description 1
• 235000009854 Cucurbita moschata Nutrition 0.000 description 1
• 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
• XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
• 206010011732 Cyst Diseases 0.000 description 1
• 206010011878 Deafness Diseases 0.000 description 1
• 206010011906 Death Diseases 0.000 description 1
• 208000019505 Deglutition disease Diseases 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 1
• 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
• 102100025027 E3 ubiquitin-protein ligase TRIM69 Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 208000027534 Emotional disease Diseases 0.000 description 1
• 241000500884 Ephemera Species 0.000 description 1
• 241000289659 Erinaceidae Species 0.000 description 1
• 241000788084 Escualosa thoracata Species 0.000 description 1
• OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
• 244000004281 Eucalyptus maculata Species 0.000 description 1
• 241000975394 Evechinus chloroticus Species 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 238000004252 FT/ICR mass spectrometry Methods 0.000 description 1
• 102000009123 Fibrin Human genes 0.000 description 1
• 108010073385 Fibrin Proteins 0.000 description 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
• 235000016623 Fragaria vesca Nutrition 0.000 description 1
• 240000009088 Fragaria x ananassa Species 0.000 description 1
• 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 206010017577 Gait disturbance Diseases 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 206010018612 Gonorrhoea Diseases 0.000 description 1
• 244000020551 Helianthus annuus Species 0.000 description 1
• 235000003222 Helianthus annuus Nutrition 0.000 description 1
• 208000032843 Hemorrhage Diseases 0.000 description 1
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
• 241000160777 Hipparchia semele Species 0.000 description 1
• 101000830203 Homo sapiens E3 ubiquitin-protein ligase TRIM69 Proteins 0.000 description 1
• 101000864057 Homo sapiens Serine/threonine-protein kinase SMG1 Proteins 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• 206010020880 Hypertrophy Diseases 0.000 description 1
• 101150034518 Iapp gene Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 241000283160 Inia Species 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 108010044467 Isoenzymes Proteins 0.000 description 1
• DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 241000254158 Lampyridae Species 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 235000004431 Linum usitatissimum Nutrition 0.000 description 1
• 240000006240 Linum usitatissimum Species 0.000 description 1
• LTGPFZWZZNUIIK-LURJTMIESA-N Lysol Chemical compound NCCCC[C@H](N)CO LTGPFZWZZNUIIK-LURJTMIESA-N 0.000 description 1
• 101150050144 MLO1 gene Proteins 0.000 description 1
• 208000002720 Malnutrition Diseases 0.000 description 1
• 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 235000014749 Mentha crispa Nutrition 0.000 description 1
• 244000078639 Mentha spicata Species 0.000 description 1
• 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
• 240000008821 Menyanthes trifoliata Species 0.000 description 1
• 101150101095 Mmp12 gene Proteins 0.000 description 1
• 102100034068 Monocarboxylate transporter 1 Human genes 0.000 description 1
• 108700038057 Monocarboxylate transporter 1 Proteins 0.000 description 1
• 208000005647 Mumps Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100323108 Mus musculus Amot gene Proteins 0.000 description 1
• 101100400779 Mus musculus Mdfi gene Proteins 0.000 description 1
• 241000282339 Mustela Species 0.000 description 1
• 241001504654 Mustela nivalis Species 0.000 description 1
• MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
• BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 101100258315 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) crc-1 gene Proteins 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 241000819999 Nymphes Species 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 241000238413 Octopus Species 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 241000237502 Ostreidae Species 0.000 description 1
• 241000283903 Ovis aries Species 0.000 description 1
• 239000012828 PI3K inhibitor Substances 0.000 description 1
• 101150037263 PIP2 gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 239000006002 Pepper Substances 0.000 description 1
• 241001387976 Pera Species 0.000 description 1
• 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
• 244000046052 Phaseolus vulgaris Species 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
• 235000011613 Pinus brutia Nutrition 0.000 description 1
• 241000018646 Pinus brutia Species 0.000 description 1
• 235000016761 Piper aduncum Nutrition 0.000 description 1
• 240000003889 Piper guineense Species 0.000 description 1
• 235000017804 Piper guineense Nutrition 0.000 description 1
• 235000008184 Piper nigrum Nutrition 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 241000219000 Populus Species 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 241000282330 Procyon lotor Species 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 240000005809 Prunus persica Species 0.000 description 1
• 235000006040 Prunus persica var persica Nutrition 0.000 description 1
• 101000690438 Prunus serotina Amygdalin beta-glucosidase 2 Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 102100034911 Pyruvate kinase PKM Human genes 0.000 description 1
• KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
• PZIBOVBPVADPBS-UHFFFAOYSA-J S(=O)(=O)([O-])[O-].[Si+4].S(=O)(=O)([O-])[O-] Chemical compound S(=O)(=O)([O-])[O-].[Si+4].S(=O)(=O)([O-])[O-] PZIBOVBPVADPBS-UHFFFAOYSA-J 0.000 description 1
• 101100262439 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UBA2 gene Proteins 0.000 description 1
• 240000005499 Sasa Species 0.000 description 1
• 241000447727 Scabies Species 0.000 description 1
• 101100411640 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rad8 gene Proteins 0.000 description 1
• 208000034189 Sclerosis Diseases 0.000 description 1
• 241000239226 Scorpiones Species 0.000 description 1
• 229940124639 Selective inhibitor Drugs 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102100029938 Serine/threonine-protein kinase SMG1 Human genes 0.000 description 1
• 229910004738 SiO1 Inorganic materials 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 208000007107 Stomach Ulcer Diseases 0.000 description 1
• PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
• 229920006328 Styrofoam Polymers 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 239000004809 Teflon Substances 0.000 description 1
• 229920006362 Teflon® Polymers 0.000 description 1
• 235000007303 Thymus vulgaris Nutrition 0.000 description 1
• 240000002657 Thymus vulgaris Species 0.000 description 1
• 241000656145 Thyrsites atun Species 0.000 description 1
• 235000011941 Tilia x europaea Nutrition 0.000 description 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 241000609666 Tuber aestivum Species 0.000 description 1
• 241000170489 Upis Species 0.000 description 1
• 235000019013 Viburnum opulus Nutrition 0.000 description 1
• 244000071378 Viburnum opulus Species 0.000 description 1
• 235000006085 Vigna mungo var mungo Nutrition 0.000 description 1
• 240000005616 Vigna mungo var. mungo Species 0.000 description 1
• 239000005862 Whey Substances 0.000 description 1
• 102000007544 Whey Proteins Human genes 0.000 description 1
• 108010046377 Whey Proteins Proteins 0.000 description 1
• 101100428341 Xenopus laevis atp6s14 gene Proteins 0.000 description 1
• URSRDDAXMAGFTC-KXXDLYTDSA-N [(2s,3s,4s,5r,6r)-5-hydroxy-2-methyl-6-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-4-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl] (e)-3-(3,4-dimethoxyphenyl)prop-2-enoate Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)[C@@H](O)[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](OCCC=3C=CC(O)=CC=3)O2)O)O[C@H]1C URSRDDAXMAGFTC-KXXDLYTDSA-N 0.000 description 1
• SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 229960000583 acetic acid Drugs 0.000 description 1
• KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
• PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
• 229920006397 acrylic thermoplastic Polymers 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 239000003732 agents acting on the eye Substances 0.000 description 1
• 230000032683 aging Effects 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 229930013930 alkaloid Natural products 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000002877 alkyl aryl group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 150000003927 aminopyridines Chemical class 0.000 description 1
• 230000006986 amnesia Effects 0.000 description 1
• 150000003931 anilides Chemical class 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000002921 anti-spasmodic effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 235000019568 aromas Nutrition 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 239000010425 asbestos Substances 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 239000012131 assay buffer Substances 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 230000000386 athletic effect Effects 0.000 description 1
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 210000003323 beak Anatomy 0.000 description 1
• 238000010009 beating Methods 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• 125000006267 biphenyl group Chemical group 0.000 description 1
• 235000019658 bitter taste Nutrition 0.000 description 1
• 239000007844 bleaching agent Substances 0.000 description 1
• 208000034158 bleeding Diseases 0.000 description 1
• 230000000740 bleeding effect Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 229910000085 borane Inorganic materials 0.000 description 1
• 229940089093 botox Drugs 0.000 description 1
• 239000011449 brick Substances 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 208000015669 capillary disease Diseases 0.000 description 1
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
• TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
• 239000006229 carbon black Substances 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 229960004562 carboplatin Drugs 0.000 description 1
• 230000021523 carboxylation Effects 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• PZIMIYVOZBTARW-UHFFFAOYSA-N centralite Chemical compound C=1C=CC=CC=1N(CC)C(=O)N(CC)C1=CC=CC=C1 PZIMIYVOZBTARW-UHFFFAOYSA-N 0.000 description 1
• 235000013339 cereals Nutrition 0.000 description 1
• 206010008129 cerebral palsy Diseases 0.000 description 1
• 208000026106 cerebrovascular disease Diseases 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000003610 charcoal Substances 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 229920005556 chlorobutyl Polymers 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 239000000812 cholinergic antagonist Substances 0.000 description 1
• ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 229910052804 chromium Inorganic materials 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 239000004567 concrete Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000013256 coordination polymer Substances 0.000 description 1
• 239000007799 cork Substances 0.000 description 1
• 230000007797 corrosion Effects 0.000 description 1
• 238000005260 corrosion Methods 0.000 description 1
• 235000019788 craving Nutrition 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 125000000753 cycloalkyl group Chemical group 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000009849 deactivation Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 235000021185 dessert Nutrition 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 235000001916 dieting Nutrition 0.000 description 1
• 230000037228 dieting effect Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• PWEVMPIIOJUPRI-UHFFFAOYSA-N dimethyltin Chemical compound C[Sn]C PWEVMPIIOJUPRI-UHFFFAOYSA-N 0.000 description 1
• 201000010099 disease Diseases 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 1
• 229960003668 docetaxel Drugs 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 229940043264 dodecyl sulfate Drugs 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 206010013932 dyslexia Diseases 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 210000002969 egg yolk Anatomy 0.000 description 1
• 230000008451 emotion Effects 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 229960003276 erythromycin Drugs 0.000 description 1
• 238000005530 etching Methods 0.000 description 1
• 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 210000000887 face Anatomy 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 150000002193 fatty amides Chemical class 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 229950003499 fibrin Drugs 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• OQZCSNDVOWYALR-UHFFFAOYSA-N flurochloridone Chemical group FC(F)(F)C1=CC=CC(N2C(C(Cl)C(CCl)C2)=O)=C1 OQZCSNDVOWYALR-UHFFFAOYSA-N 0.000 description 1
• 238000011010 flushing procedure Methods 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 239000000446 fuel Substances 0.000 description 1
• ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 239000010437 gem Substances 0.000 description 1
• 229910001751 gemstone Inorganic materials 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 208000019061 glycogen storage disease due to GLUT2 deficiency Diseases 0.000 description 1
• 208000001786 gonorrhea Diseases 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 125000001188 haloalkyl group Chemical group 0.000 description 1
• 125000001475 halogen functional group Chemical group 0.000 description 1
• 230000012447 hatching Effects 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 239000001307 helium Substances 0.000 description 1
• 229910052734 helium Inorganic materials 0.000 description 1
• SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
• 208000014617 hemorrhoid Diseases 0.000 description 1
• 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 230000002363 herbicidal effect Effects 0.000 description 1
• 239000004009 herbicide Substances 0.000 description 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 235000003642 hunger Nutrition 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
• 229960000240 hydrocodone Drugs 0.000 description 1
• OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 201000001421 hyperglycemia Diseases 0.000 description 1
• 235000015243 ice cream Nutrition 0.000 description 1
• 239000012216 imaging agent Substances 0.000 description 1
• 150000003949 imides Chemical class 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000008676 import Effects 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
• 229910052741 iridium Inorganic materials 0.000 description 1
• GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 238000000021 kinase assay Methods 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 238000000370 laser capture micro-dissection Methods 0.000 description 1
• 238000002386 leaching Methods 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 238000007443 liposuction Methods 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 235000011475 lollipops Nutrition 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 208000003747 lymphoid leukemia Diseases 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 230000001071 malnutrition Effects 0.000 description 1
• 235000000824 malnutrition Nutrition 0.000 description 1
• 210000005075 mammary gland Anatomy 0.000 description 1
• 101150024228 mdm2 gene Proteins 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 239000000155 melt Substances 0.000 description 1
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
• 229960001428 mercaptopurine Drugs 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
• UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
• QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
• ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
• 229910052750 molybdenum Inorganic materials 0.000 description 1
• 239000011733 molybdenum Substances 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 208000010805 mumps infectious disease Diseases 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• 150000002825 nitriles Chemical class 0.000 description 1
• 239000012299 nitrogen atmosphere Substances 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• 230000000422 nocturnal effect Effects 0.000 description 1
• 239000002687 nonaqueous vehicle Substances 0.000 description 1
• 239000012038 nucleophile Substances 0.000 description 1
• 230000000269 nucleophilic effect Effects 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 208000015380 nutritional deficiency disease Diseases 0.000 description 1
• 235000014571 nuts Nutrition 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229940125702 ophthalmic agent Drugs 0.000 description 1
• 239000012074 organic phase Substances 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 150000004893 oxazines Chemical class 0.000 description 1
• 235000020636 oyster Nutrition 0.000 description 1
• 125000005440 p-toluyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C(*)=O)C([H])([H])[H] 0.000 description 1
• 239000005022 packaging material Substances 0.000 description 1
• 239000003973 paint Substances 0.000 description 1
• 235000012771 pancakes Nutrition 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 239000012466 permeate Substances 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 229940049953 phenylacetate Drugs 0.000 description 1
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
• VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
• IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 125000001095 phosphatidyl group Chemical group 0.000 description 1
• 229940043441 phosphoinositide 3-kinase inhibitor Drugs 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• PVFZKRMYBKEXBN-UHFFFAOYSA-N piperidine;piperidine-1-carbodithioic acid Chemical compound C1CCNCC1.SC(=S)N1CCCCC1 PVFZKRMYBKEXBN-UHFFFAOYSA-N 0.000 description 1
• 125000005936 piperidyl group Chemical group 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 235000012830 plain croissants Nutrition 0.000 description 1
• 239000011505 plaster Substances 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 235000021018 plums Nutrition 0.000 description 1
• 239000002574 poison Substances 0.000 description 1
• 231100000614 poison Toxicity 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 229920000232 polyglycine polymer Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 229960004583 pranlukast Drugs 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 244000062645 predators Species 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• 125000006239 protecting group Chemical group 0.000 description 1
• 239000003909 protein kinase inhibitor Substances 0.000 description 1
• 239000008262 pumice Substances 0.000 description 1
• 235000015136 pumpkin Nutrition 0.000 description 1
• 238000004080 punching Methods 0.000 description 1
• 125000004526 pyridazin-2-yl group Chemical group N1N(C=CC=C1)* 0.000 description 1
• MQDVUDAZJMZQMF-UHFFFAOYSA-N pyridin-2-ylurea Chemical compound NC(=O)NC1=CC=CC=N1 MQDVUDAZJMZQMF-UHFFFAOYSA-N 0.000 description 1
• HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
• 239000010453 quartz Substances 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 230000007420 reactivation Effects 0.000 description 1
• 239000013074 reference sample Substances 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000003716 rejuvenation Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000029054 response to nutrient Effects 0.000 description 1
• 208000037803 restenosis Diseases 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 229940083045 riax Drugs 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 229910052895 riebeckite Inorganic materials 0.000 description 1
• 239000011435 rock Substances 0.000 description 1
• 101150028481 rol-3 gene Proteins 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 235000015067 sauces Nutrition 0.000 description 1
• 208000005687 scabies Diseases 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 239000002893 slag Substances 0.000 description 1
• 238000002791 soaking Methods 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 125000004436 sodium atom Chemical group 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 210000005070 sphincter Anatomy 0.000 description 1
• 235000013599 spices Nutrition 0.000 description 1
• 125000003003 spiro group Chemical group 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 239000012089 stop solution Substances 0.000 description 1
• 239000008261 styrofoam Substances 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical group S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 238000010408 sweeping Methods 0.000 description 1
• 230000009182 swimming Effects 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 208000006379 syphilis Diseases 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 229920001864 tannin Polymers 0.000 description 1
• 239000001648 tannin Substances 0.000 description 1
• 235000018553 tannin Nutrition 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 229940063683 taxotere Drugs 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
• RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
• ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 230000035922 thirst Effects 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 239000001585 thymus vulgaris Substances 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
• UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 1
• 229960000303 topotecan Drugs 0.000 description 1
• KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
• LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 229940055764 triaz Drugs 0.000 description 1
• 150000003852 triazoles Chemical class 0.000 description 1
• QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Substances FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 1
• XFSPFPFUBRZQFO-UHFFFAOYSA-N trifluoromethyl dihydrogen phosphate Chemical compound OP(O)(=O)OC(F)(F)F XFSPFPFUBRZQFO-UHFFFAOYSA-N 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• 108010036387 trimethionine Proteins 0.000 description 1
• 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
• 125000005289 uranyl group Chemical group 0.000 description 1
• 150000003672 ureas Chemical class 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 206010046885 vaginal cancer Diseases 0.000 description 1
• 208000013139 vaginal neoplasm Diseases 0.000 description 1
• 229910052720 vanadium Inorganic materials 0.000 description 1
• RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 1
• 239000000052 vinegar Substances 0.000 description 1
• 235000021419 vinegar Nutrition 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 239000011800 void material Substances 0.000 description 1
• 230000036642 wellbeing Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 210000004885 white matter Anatomy 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• 235000013618 yogurt Nutrition 0.000 description 1
• 229910052727 yttrium Inorganic materials 0.000 description 1